MP89-05 EFFECT OF ICARISIDE II ON MIR-126 PATHWAY ON HUMAN CAVERNOUS ENDOTHELIAL CELLS EXPOSED TO A DIABETIC-LIKE ENVIRONMENT

Ruili Guan,Hongen Lei,Bicheng Yang,Zhezhu Gao,Lin Wang,Huixi Li,Zhongcheng Xin

DOI: https://doi.org/10.1016/j.juro.2016.02.2466

2016-01-01

Abstract:growth factor, we determined the effectiveness of recombinant human hepatocyte growth factor (rh-HGF) protein in diabetic mice.METHODS: Diabetes was induced by intraperitoneal injection of streptozotocin into 8-week-old C57BL/6 male mice.At 8 weeks after the induction of diabetes, the animals were divided into 4 groups: control nondiabetic mice and diabetic mice receiving two successive intracavernous injections of phosphate-buffered saline (days -3 and 0; 20 mL), a single intracavernous injection of rh-HGF protein (day 0; 4.2 mg/20 mL of PBS), or two successive intracavernous injections of rh-HGF protein (days -3 and 0; 4.2 mg/20 mL, respectively).Two weeks after treatment, we measured erectile function by electrical stimulation of the cavernous nerve.The penis was harvested for histologic and biochemical studies.RESULTS: Repeated intracavernous injections of rh-HGF protein induced significant restoration of erectile function in diabetic mice (90% of control values), whereas a single intracavernous injection of rh-HGF protein elicited modest improvement.Rh-HGF significantly increased the content of endothelial cells, pericytes, and smooth muscle cells and decreased the generation of reactive oxygen species (superoxide anion and peroxynitrite) and extravasation of oxidized LDL in diabetic mice.Rh-HGF protein also promoted tube formation in primary cultured mouse cavernous endothelial cells and pericytes in vitro.CONCLUSIONS: Re-establishment of functional and structural cavernous vasculature by use of potent angiogenic factor protein, HGF, is a highly promising treatment modality for ED from vascular causes.